[
    [
        {
            "time": "",
            "original_text": "位药企高管辞职了！董监高成员变化",
            "features": {
                "keywords": [
                    "药企",
                    "高管",
                    "辞职",
                    "董监高",
                    "成员变化"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "位药企高管辞职了！董监高成员变化",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[INCREASE评级] CHUANC AI RESEARCH 2018 STRATEGY REPORT：2018 CHINA EQUITY MARKET PHARMACEUTICAL OUTLOOK",
            "features": {
                "keywords": [
                    "INCREASE评级",
                    "CHUANC AI RESEARCH",
                    "2018",
                    "策略报告",
                    "中国股市",
                    "医药行业展望"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[INCREASE评级] CHUANC AI RESEARCH 2018 STRATEGY REPORT：2018 CHINA EQUITY MARKET PHARMACEUTICAL OUTLOOK",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "千山药机基因梦碎：从十倍牛股到深陷债务危局",
            "features": {
                "keywords": [
                    "千山药机",
                    "基因",
                    "梦碎",
                    "牛股",
                    "债务危局"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "千山药机基因梦碎：从十倍牛股到深陷债务危局",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]